Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析

◆英語タイトル:Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0980
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sangui BioTech International Inc (SGBI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sangui Biotech International Inc (Sangui Biotech), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. Sangui Biotech’s product portfolio includes artificial oxygen carriers, nano formulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. It markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. Sangui Biotech is headquartered in Witten, Nordrhein-Westfalen, Germany.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sangui BioTech International Inc – Key Facts
Sangui BioTech International Inc – Key Employees
Sangui BioTech International Inc – Key Employee Biographies
Sangui BioTech International Inc – Major Products and Services
Sangui BioTech International Inc – History
Sangui BioTech International Inc – Company Statement
Sangui BioTech International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sangui BioTech International Inc – Business Description
R&D Overview
Sangui BioTech International Inc – Corporate Strategy
Sangui BioTech International Inc – SWOT Analysis
SWOT Analysis – Overview
Sangui BioTech International Inc – Strengths
Sangui BioTech International Inc – Weaknesses
Sangui BioTech International Inc – Opportunities
Sangui BioTech International Inc – Threats
Sangui BioTech International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sangui BioTech International Inc, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sangui BioTech International Inc, Key Facts
Sangui BioTech International Inc, Key Employees
Sangui BioTech International Inc, Key Employee Biographies
Sangui BioTech International Inc, Major Products and Services
Sangui BioTech International Inc, History
Sangui BioTech International Inc, Subsidiaries
Sangui BioTech International Inc, Key Competitors
Sangui BioTech International Inc, Ratios based on current share price
Sangui BioTech International Inc, Annual Ratios
Sangui BioTech International Inc, Annual Ratios (Cont...1)
Sangui BioTech International Inc, Interim Ratios
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sangui BioTech International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sangui BioTech International Inc, Performance Chart (2015 - 2019)
Sangui BioTech International Inc, Ratio Charts
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qisda Corporation:戦略・SWOT・企業財務分析
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • John Keells Hotels Plc:企業の戦略・SWOT・財務分析
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Banesco Banco Universal C.A.:企業の戦略・SWOT・財務情報
    Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report Summary Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Southern Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Southern Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • iBio Inc (IBIO)-製薬・医療分野:企業M&A・提携分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, …
  • Arthrex Inc:企業の戦略的SWOT分析
    Arthrex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Saudi Arabian Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Saudi Arabian Oil Co (Saudi Aramco) is an integrated energy and chemcials company. It is a state-owned enterprise that carries out exploration, production and processing of crude oil and natural gas, refining, fractionation of natural gas, production of petrochemicals, and distribution of pe …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Gexa Energy LP:企業の戦略的SWOT分析
    Gexa Energy LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …
  • Mediware Information Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • XyloCor Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary XyloCor Therapeutics Inc (XyloCor Therapeutics) is a biopharmaceutical company that offers development of gene therapies for cardiovascular diseases. The company’s portfolio of pipeline products includes XC001 and XC002. It develops its products for the treatment of refractory angina and for …
  • Groupe Lactalis S.A.:企業の戦略・SWOT・財務情報
    Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Denizbank A.S.
    Denizbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Denizbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathie …
  • Hansa Medical AB (HMED):製薬・医療:M&Aディール及び事業提携情報
    Summary Hansa Medical AB (Hansa Medical) is a biopharmaceutical company that focuses on the development of novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The company's lead project, IdeS is a proprietary antibody-degrading enzyme in late stage clinical development …
  • SK Telecom Co Ltd (017670):企業の財務・戦略的SWOT分析
    SK Telecom Co Ltd (017670) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆